159 related articles for article (PubMed ID: 30411384)
1. Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy.
Meiss F; Technau-Hafsi K; Kern JS; May AM
J Cutan Pathol; 2019 Mar; 46(3):175-181. PubMed ID: 30411384
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic dermatosis of hematologic malignancy.
Farber MJ; La Forgia S; Sahu J; Lee JB
J Cutan Pathol; 2012 Jul; 39(7):690-5. PubMed ID: 22612903
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic folliculitis, eosinophilic dermatosis of hematologic malignancy and acneiform follicular mucinosis: Two case reports and a review of the literature highlighting the spectrum of histopathology.
Bailey CAR; Laurain DA; Sheinbein DM; Jones HA; Compton LA; Rosman IS
J Cutan Pathol; 2021 Mar; 48(3):439-450. PubMed ID: 33617128
[TBL] [Abstract][Full Text] [Related]
4. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?
Qiao J; Sun CE; Zhu W; Zhu D; Fang H
Int J Clin Exp Pathol; 2013; 6(8):1683-7. PubMed ID: 23923089
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic dermatosis of haematological malignancy.
Jayasekera PS; Bakshi A; Al-Sharqi A
Clin Exp Dermatol; 2016 Aug; 41(6):692-5. PubMed ID: 27378400
[No Abstract] [Full Text] [Related]
6. Eosinophilic dermatosis of hematologic malignancy: a case report.
Almeida FT; Caldas R; Rodrigues AP; Ferreira O; Brito C
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609451
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic Dermatosis of Hematologic Malignancy.
Lucas-Truyols S; Rodrigo-Nicolás B; Lloret-Ruiz C; Quecedo-Estébanez E
Actas Dermosifiliogr; 2017; 108(6):e39-e44. PubMed ID: 28342533
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic dermatosis of hematologic malignancy.
Martires K; Callahan S; Terushkin V; Brinster N; Leger M; Soter NA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329554
[TBL] [Abstract][Full Text] [Related]
9. T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity.
Visseaux L; Durlach A; Barete S; Beylot-Barry M; Bonnet N; Chassine A; Franck N; Herve G; Leclec'h C; Machet L; Ingen-Housz-Oro S; Petrella T; Vergier B; Ortonne N; Grange F
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1469-1475. PubMed ID: 29356170
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia and the skin: implications for the dermatologist.
Fried LJ; Criscito MC; Stevenson ML; Pomeranz MK
Int J Dermatol; 2022 May; 61(5):519-531. PubMed ID: 33951189
[TBL] [Abstract][Full Text] [Related]
11. What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).
Cohen PR
Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815699
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic dermatosis in a patient with chronic lymphocytic leukemia: a rare case report.
Gardikioti A; Venou TM; Mainou M; Nikolaidou C; Klonizakis P; Vetsiou E; Psarras K; Vlachaki E
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Dec; 30(4):161-164. PubMed ID: 34929993
[TBL] [Abstract][Full Text] [Related]
13. Dense lymphocytic infiltrates associated with non-melanoma skin cancer in patients with chronic lymphocytic leukemia.
Wilson ML; Elston DM; Tyler WB; Marks VJ; Ferringer T
Dermatol Online J; 2010 Mar; 16(3):4. PubMed ID: 20233561
[TBL] [Abstract][Full Text] [Related]
14. [Eosinophilic dermatosis associated with hematological disorders: A clinical, histopathological and immunohistochemical study of six observations].
Chassine AF; Dadban A; Charfi S; Chaby G; Royer B; Damaj G; Chatelain D; Lok C
Ann Dermatol Venereol; 2010 Mar; 137(3):181-8. PubMed ID: 20227559
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.
Sato-Sano M; Teixeira SP; Vargas JC; Baiocchi OCCG; Enokihara MMSES; Gomes EE; Batista MD
J Dermatol; 2019 Jul; 46(7):618-621. PubMed ID: 31144726
[TBL] [Abstract][Full Text] [Related]
16. B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma.
Neuber K; Berg-Drewniock B; Volkenandt M; Neumaier M; Zeller W; Gross G; Ring J
Dermatology; 1996; 192(2):110-5. PubMed ID: 8829490
[TBL] [Abstract][Full Text] [Related]
17. Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemia.
Plaza JA; Comfere NI; Gibson LE; Colgan M; Davis DM; Pittelkow MR; Colgan JP
J Am Acad Dermatol; 2009 May; 60(5):772-80. PubMed ID: 19389520
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic Dermatosis of Malignancy Involving the Eyelid.
Ho TC; Compton L; Sheinbein D; Custer PL
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):e196-e198. PubMed ID: 34269770
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.
Bari O; Cohen PR
Dermatol Pract Concept; 2017 Jul; 7(3):6-15. PubMed ID: 29085714
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
Jin A; Pousti BT; Savage KT; Mollanazar NK; Lee JB; Hsu S
JAAD Case Rep; 2019 Sep; 5(9):815-817. PubMed ID: 31508473
[No Abstract] [Full Text] [Related]
[Next] [New Search]